Log in
Upstream
Contact
Assoc. Prof Pemberton has 18 years experience in the discovery and validation of circulating protein markers. He is also a senior member of the Christchurch Heart Institute, New Zealand’s premier cardiovascular research group.
View in org chart
Kieran Jina
CEO
Chris Pemberton
VP of Discovery
Jan Powell
VP of Research
Roland Toder
Executive Director
David Christensen
Director
+ 1 more
4 members
1 members
5 members
Current role
VP of Discovery at Cellphire Therapeutics
VP of Discovery at Athira Pharma
VP of Discovery at Aria Pharmaceuticals
Co-Founder & VP of Discovery at Convelo Therapeutics
VP of Discovery at Reglagene